HealthcareServices

Polygenic Risk Score Services Market Research: Growth Projections and Trends 2030

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the polygenic risk score services market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Polygenic Risk Score Services Market expected to reach by 2030?

The polygenic risk score services market has observed rapid expansion in recent years. It is projected to grow from $1.45 billion in 2025 to $1.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.7%. The market’s historical growth can be linked to the increase in large-scale genotyping studies, greater access to genomic databases, the expansion of preventive healthcare programs, a rising focus on genetic risk assessment, and advancements in statistical genetics methods.

The polygenic risk score services market is set for substantial expansion in the coming years, with projections indicating it will reach $3.11 billion by 2030, maintaining a compound annual growth rate (CAGR) of 16.4%. This anticipated growth stems from factors such as the increasing clinical application of risk stratification tools, the growing integration of polygenic risk scores (PRS) into personalized medicine, the expansion of preventive genomics programs, a rising demand for interoperable genetic data platforms, and enhanced regulatory clarity for genetic services. Significant trends expected during this forecast period include the wider adoption of polygenic risk prediction algorithms, a greater integration of PRS with clinical decision-making tools, an escalating need for population-specific risk models, the broadening of direct-to-consumer genetic risk services, and an intensified focus on data security and privacy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28302&type=smp

What Drivers Are Driving Adoption Within The Polygenic Risk Score Services Market?

The increasing focus on personalized medicine is anticipated to propel the growth of the polygenic risk score (PRS) services market in the future. This healthcare approach involves customizing prevention, diagnosis, and treatment based on an individual’s unique genetic makeup, environmental influences, and lifestyle choices. Its rise is attributed to advancements in genomics, which offer enhanced understanding of individual genetic variations, thereby enabling more accurate and focused therapeutic approaches. The polygenic risk score services market plays a crucial role in this trend by examining numerous genetic variants to assess disease risk, empowering clinicians to develop tailored prevention strategies, implement early interventions, and create customized treatment plans specific to each patient’s genetic profile. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, which was an increase from six approvals in 2022, in addition to seven personalized cancer drugs and three treatments for other conditions. Consequently, the heightened emphasis on personalized medicine is stimulating the growth of the polygenic risk score services market.

What Segments Are Included Within The Polygenic Risk Score Services Market?

The polygenic risk score services market covered in this report is segmented –

1) By Service Type: Genotyping, Sequencing, Data Analysis, Reporting, Other Service Types

2) By Application: Disease Risk Assessment, Personalized Medicine, Research, Other Applications

3) By End-User: Hospitals And Clinics, Research Institutes, Direct-to-Consumer, Other End-Users

Subsegments:

1) By Genotyping: Array-Based Genotyping, Targeted Genotyping, High-Throughput Genotyping

2) By Sequencing: Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Targeted Sequencing

3) By Data Analysis: Polygenic Risk Prediction Algorithms, Bioinformatics And Statistical Analysis, Data Integration With Electronic Health Records (Ehr)

4) By Reporting: Clinical Reports For Healthcare Providers, Direct-To-Consumer (Dtc) Reports, Risk Stratification Reports (Disease-Specific)

5) By Other Service Types: Genetic Counseling Services, Data Storage And Cloud-Based Platforms, Prs Software And Toolkits

What Trends Are Projected To Support The Growth Of The Polygenic Risk Score Services Market?

Leading companies operating in the polygenic risk score services market are focusing on developing innovative solutions like pharmacogenomics to enhance personalized treatment strategies and improve patient outcomes. Pharmacogenomics refers to the study of how an individual’s genetic makeup influences their response to drugs, enabling more precise and personalized treatment. For instance, in July 2025, Bupa, a UK-based health insurance company, launched a new suite of DNA-based tests to support personalized health and wellness insights. This suite offers personalized insights on medication response and disease risk, enabling earlier detection and tailored treatment for conditions such as cancer, diabetes, and heart disease. These tests help prevent side effects, improve long-term health outcomes, and empower individuals to take proactive steps for themselves and their families. The purpose is to shift healthcare from reactive treatment to preventive, precision health management.

Who Are The Core Companies Influencing Trends In The Polygenic Risk Score Services Market?

Major companies operating in the polygenic risk score services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Illumina Inc., Endeavor Health Inc., Myriad Genetics Inc., The Broad Institute of MIT and Harvard, BGI Group, Invitae Corporation, 23andMe Holding Co., Color Health Inc., Genomics Ltd., Cogentech S.R.L., Gene by Gene Ltd., Our Future Health Ltd., Mapmygenome India Limited, Australian Genome Research Facility (AGRF) Ltd., Golden Helix Inc., Allelica Inc., Antegenes OÜ, GeninCode Plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/polygenic-risk-score-services-global-market-report

Which Regions Are Projected To Dominate The Polygenic Risk Score Services Market In The Coming Years?

North America was the largest region in the polygenic risk score services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polygenic risk score services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Polygenic Risk Score Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28302&type=smp

Browse Through More Reports Similar to the Global Polygenic Risk Score Services Market 2026, By The Business Research Company

Integrated Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/integrated-risk-management-software-global-market-report

Genetic Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Risk Management Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/risk-management-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795